Medium Biosciences
AI-designed Protein Therapeutics
San Francisco, United States · Founded 2021
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Website
- medium.bio
- Last Round
- SeedMar 2021
- Rounds
- 1
About
We develop AI models & new assays to create functional, therapeutic proteins.
Summary
Medium Biosciences is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. Its most recent funding was a Seed round in Mar 2021. Investors include E14 Fund, AIX Ventures and Village Global.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2021
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/medium-biosciences"><img src="https://indexed.vc/api/badge/company/medium-biosciences" alt="Medium Biosciences on Indexed.vc" width="260" height="76" /></a>